
Aurisco Pharmaceutical Co.,Ltd.
SSE:605116.SS
21.07 (CNY) • At close June 6, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
2025 Q1 | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities: | |||||||||||||||||||||||
Net Income
| 0 | 0 | 95.203 | 106.408 | 82.184 | 56.873 | 136.65 | 50.019 | 45.878 | 24.501 | 69.656 | 75.886 | 40.853 | 35.198 | 50.539 | 50.404 | 32.573 | 17.022 | 37.142 | 53.055 | 50.008 | 66.256 | 47.838 |
Depreciation & Amortization
| 0 | 0 | 0 | 22.211 | 22.211 | 20.978 | -38.182 | 19.846 | 19.846 | 17.741 | 17.741 | 17.658 | 17.658 | 15.899 | 15.899 | 12.203 | 12.203 | 32.024 | -16.31 | 16.31 | 0 | 27.9 | 0 |
Deferred Income Tax
| 0 | 0 | 0 | 0 | 0 | 0 | -10.153 | -5.42 | 0 | 211.218 | -35.459 | 80.916 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Stock Based Compensation
| 0 | 0 | 0 | 10.715 | 0 | 8.154 | -17.692 | 17.692 | 0 | 6.349 | -2.039 | 2.039 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Change In Working Capital
| 0 | 0 | 0 | -96.175 | 0 | -136.422 | 52.789 | -52.789 | 0 | -210.807 | 89.413 | -89.413 | 0 | -76.71 | 30.895 | -30.895 | 0 | -16.365 | 2.409 | -2.409 | 0 | -66.254 | 0 |
Accounts Receivables
| 0 | 0 | 0 | -65.511 | 0 | -98.179 | -0.728 | 0.728 | 0 | -84.833 | 49.443 | -49.443 | 0 | 11.294 | 2.474 | -2.474 | 0 | -20.723 | 8.104 | -8.104 | 0 | -21.196 | 0 |
Change In Inventory
| 0 | 0 | 0 | -43.634 | 0 | -72.519 | 53.518 | -53.518 | 0 | -125.974 | 39.969 | -39.969 | 0 | -89.005 | 30.729 | -30.729 | 0 | 1.828 | -3.234 | 3.234 | 0 | -11.464 | 0 |
Change In Accounts Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 20.785 | -20.785 | 0 | -17.984 | 3.997 | -3.997 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Working Capital
| 0 | 0 | 0 | 12.97 | 0 | 34.276 | -20.785 | 20.785 | 0 | 17.984 | -3.997 | 3.997 | 0 | 1.002 | -2.308 | 2.308 | 0 | 2.53 | -2.46 | 2.46 | 0 | -33.594 | 0 |
Other Non Cash Items
| 0 | 0 | 39.732 | -5.176 | 7.72 | 46.779 | 17.912 | 38.365 | -19.846 | -24.501 | -69.656 | -11.2 | -15.474 | 21.977 | -50.539 | -50.404 | -32.573 | -17.022 | -37.142 | -53.055 | -50.008 | -66.256 | -47.838 |
Operating Cash Flow
| 0 | 0 | 134.935 | 79.02 | 89.904 | 82.674 | 141.324 | 67.714 | 45.878 | 24.501 | 69.656 | 75.886 | 25.379 | 41.057 | 71.73 | 65.249 | 23.535 | 10.04 | 73.204 | 113.055 | 18.182 | 50.431 | 0 |
Investing Activities: | |||||||||||||||||||||||
Investments In Property Plant And Equipment
| -108.222 | -102.057 | -184.455 | -113.206 | -140.559 | -111.43 | -85.693 | -66.621 | -41.732 | -93.08 | -31.554 | -40.513 | -51.079 | -128.108 | -46.93 | -29.209 | -46.367 | -62.681 | -44.089 | -33.146 | -18.884 | -15.935 | -20.103 |
Acquisitions Net
| 0 | 0 | 0 | 0.124 | 0.063 | 62.474 | 0.188 | 0.082 | 0.071 | 0.248 | 0.072 | 0.225 | 0.081 | -1.984 | 47.269 | 0.155 | 0.087 | 62.884 | 44.1 | 0 | 0 | 4.758 | 19.819 |
Purchases Of Investments
| -224.28 | -139.778 | 585.335 | -758.135 | 0 | -121.438 | -0.188 | 0.413 | -0.413 | -11.441 | -30 | -50 | 0 | -26.137 | -30 | -20 | -35 | -40 | 20 | 0 | -32 | -130 | 20 |
Sales Maturities Of Investments
| 269.135 | -107.609 | -647.564 | 757.135 | 0.477 | -59.035 | 58.238 | -0.495 | -0.071 | 20.041 | 30.076 | 49.775 | 0 | 56.356 | 20.167 | 20 | 0 | 52.47 | -20 | 0 | 0 | 200.821 | -49.789 |
Other Investing Activites
| 0.172 | 215.528 | -213.969 | 120 | 0.54 | -121.132 | 1.32 | 1.32 | 0.071 | 0 | 0 | -49.638 | 0.081 | 2.016 | -46.93 | 20.447 | 0.087 | -62.681 | -44.089 | 21.087 | 0.02 | -15.935 | -19.346 |
Investing Cash Flow
| -63.196 | -133.916 | -460.653 | 5.918 | -140.019 | -231.762 | -26.135 | -65.302 | -42.074 | -84.231 | -31.407 | -90.151 | -50.998 | -95.873 | -56.425 | -28.762 | -81.28 | -50.008 | -44.079 | -12.059 | -50.864 | 43.71 | -49.419 |
Financing Activities: | |||||||||||||||||||||||
Debt Repayment
| 21.175 | 96.148 | 656.069 | 48.18 | 34.975 | 27.928 | 32.125 | 3.742 | 5.675 | 30.277 | -0.325 | 2.705 | 3.46 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Common Stock Issued
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.132 | -1.132 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 | -1.2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Dividends Paid
| -1.279 | -6.23 | -3.421 | -89.363 | -0.247 | -64.991 | -0.344 | -65.737 | -0.539 | -52.337 | -2.072 | -50.203 | 0 | 0 | 0 | -48.12 | 0 | 0 | 0 | 0 | -36 | 0 | 0 |
Other Financing Activities
| -16.921 | -91.852 | 92.505 | 2.406 | -2.406 | 18.467 | -1.019 | 29.484 | -0.383 | 1.407 | -0.103 | -50.203 | 0 | -3.234 | 2 | 0 | -1.132 | -26.838 | 309.78 | 0 | 0 | 0.76 | 0 |
Financing Cash Flow
| 2.976 | -1.934 | 745.153 | -41.174 | 32.323 | 46.015 | 30.762 | -32.511 | 4.753 | 31.622 | -2.5 | -47.497 | 3.46 | -5.234 | 2 | -48.12 | -1.132 | -26.838 | 309.78 | 0 | -36 | 0.76 | 0 |
Other Information: | |||||||||||||||||||||||
Effect Of Forex Changes On Cash
| 2.693 | 15.985 | 3.551 | -10.037 | 4.52 | -1.526 | -1.027 | 7.511 | 1.154 | -3.565 | 3.886 | 3.608 | -0.427 | -1.782 | 0.286 | -1.075 | -1.255 | -4.714 | -2.273 | -0.331 | 1.025 | -8.418 | 1.784 |
Net Change In Cash
| -31.821 | -88.945 | 422.986 | -86.655 | -13.749 | -90.564 | 144.925 | -22.588 | 43.692 | 21.64 | -13.694 | -87.151 | -22.586 | -61.831 | 17.591 | -12.708 | -60.133 | -71.519 | 336.633 | 100.665 | -67.656 | 86.482 | -7.144 |
Cash At End Of Period
| 736.603 | 768.03 | 856.975 | 446.915 | 400.662 | 414.011 | 504.575 | 359.65 | 382.238 | 338.546 | 316.906 | 330.6 | 417.751 | 440.337 | 502.168 | 484.576 | 497.285 | 557.417 | 628.937 | 292.304 | 191.638 | 259.295 | 172.813 |